The Andersons, Inc. (ANDE) Tops Q1 EPS by 12c

The Andersons, Inc. (NASDAQ: ANDE) reported Q1 EPS of $0.98, $0.12 better than the analyst estimate of $0.86. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.13 billion.

For earnings history and earnings-related data on The Andersons, Inc. (ANDE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c
• Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c